Kezar Life Sciences
107 hedge funds and large institutions have $674M invested in Kezar Life Sciences in 2021 Q4 according to their latest regulatory filings, with 39 funds opening new positions, 34 increasing their positions, 22 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
55% more repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 22
41% more funds holding
Funds holding: 76 → 107 (+31)
2.39% more ownership
Funds ownership: 5.83% → 8.22% (+2.4%)
Holders
107
Holding in Top 10
5
Calls
$5.42M
Puts
$1.59M
Top Buyers
| 1 | +$49.6M | |
| 2 | +$35.2M | |
| 3 | +$34.4M | |
| 4 |
IC
Ikarian Capital
Dallas,
Texas
|
+$17.1M |
| 5 |
Holocene Advisors
New York
|
+$16.8M |
Top Sellers
| 1 | -$44.3M | |
| 2 | -$9.94M | |
| 3 | -$8.2M | |
| 4 |
PM
Prosight Management
Dallas,
Texas
|
-$4.51M |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
-$3.55M |